REQUEST A DEMO
Total
USD $0.00
Search more companies

Bat-19 Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Pharmaceutical Preparation Manufacturing | Medical Equipment and Supplies Manufacturing | Computer and Computer Peripheral Equipment and Software Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Pharmacies and Drug Stores | Other Publishers | Computer Systems Design and Related Services
Full name: Bat-19 Sp. z o.o. Profile Updated: July 25, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Bat-19 Sp. z o.o. is an enterprise located in Poland, with the main office in Krakow. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. The enterprise was incorporated on January 13, 2023. Its’ total assets recorded a negative growth of 71.15%.

Headquarters
Ul. Zablocie 20/22
Krakow; Malopolskie; Postal Code: 30-701

Contact Details: Purchase the Bat-19 Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Bat-19 Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Bat-19 Sp. z o.o. report to view the information.
Incorporation Date:
January 13, 2023
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
95%
Company Performance
Financial values in the chart are available after Bat-19 Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total operating revenue
-100%
Operating profit (EBIT)
88.62%
EBITDA
88.62%
Net Profit (Loss) for the Period
88.16%
Total Assets
-71.15%
Total Equity
-13.88%
Return on Equity (ROE)
-105.03%
Debt/Equity
96.87%
Quick Ratio
-0.32%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?